Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014, Article ID 524650, 11 pages
http://dx.doi.org/10.1155/2014/524650
Research Article

A Platform for Screening Potential Anticholinesterase Fractions and Components Obtained from Anemarrhena asphodeloides Bge for Treating Alzheimer’s Disease

1School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China
2School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China
3Key Laboratory of Structure-Based, Drug Design & Discovery, Ministry of Education, Shenyang, Liaoning 110016, China

Received 4 November 2013; Revised 2 March 2014; Accepted 20 March 2014; Published 17 April 2014

Academic Editor: Chuthamanee Suthisisang

Copyright © 2014 Yu Sun et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [2 citations]

The following is the list of published articles that have cited the current article.

  • Yu Sun, Jie Wu, Xue Sun, Xiaoxiao Huang, Lingzhi Li, Qingbo Liu, and ShaoJiang Song, “Steroids from the rhizome of Anemarrhena asphodeloides and their cytotoxic activities,” Bioorganic & Medicinal Chemistry Letters, vol. 26, no. 13, pp. 3081–3085, 2016. View at Publisher · View at Google Scholar
  • Rosa Tundis, Marco Bonesi, Francesco Menichini, and Monica R. Loizzo, “Recent Knowledge on Medicinal Plants as Source of Cholinesterase Inhibitors for the Treatment of Dementia,” Mini-Reviews In Medicinal Chemistry, vol. 16, no. 8, pp. 605–618, 2016. View at Publisher · View at Google Scholar